Key result
DX ICD detects subclinical AF at comparable rates to standard dual-chamber ICDs.
Why the study?
Comparisons between DX ICDs with an atrial floating dipole and dual-chamber (DDD) ICDs for atrial monitoring are limited in patients without an indication for atrial pacing.
Does the DX ICD provide comparable detection of new-onset device-detected atrial fibrillation compared to standard DDD ICDs in patients without an indication for atrial pacing?
Cohort (n=1,329)
Yes
Does the DX ICD provide comparable detection of new-onset device-detected atrial fibrillation compared to standard DDD ICDs in patients without an indication for atrial pacing?
Answers are grounded in this paper and cite their sources.
The DX ICD with a floating atrial dipole provides comparable subclinical atrial fibrillation detection to conventional dual-chamber ICDs in patients without a pacing indication.
BACKGROUND: Device-detected subclinical atrial fibrillation (DDAF) is a significant risk factor for major cardiovascular events, especially in implantable cardioverter-defibrillator (ICD) recipients. The DX ICD, which utilizes a single ventricular lead with a floating atrial dipole, has demonstrated superior performance in diagnosing DDAF compared to conventional single-lead ICDs. However, comparisons between DX and dual-chamber (DDD) ICDs for atrial monitoring are limited. OBJECTIVE: To compare the incidence of newly detected DDAF in patients without an indication for atrial pacing who received either a DX or a standard DDD ICD. METHODS: Remote transmissions from the Italian Home Monitoring Expert Alliance dataset were analyzed. DDAF incidence for different burden cutoffs ( ≥ 15 min, ≥ 6 h, and ≥ 24 h) was compared between groups using propensity score (PS) matching to adjust for baseline characteristics. RESULTS: In a cohort of 1329 patients (527 with DX ICD and 802 with DDD ICD), 30.7% experienced DDAF lasting ≥ 15 min, 22.3% ≥ 6 h, and 14.0% ≥ 24 h during a median follow-up of 4.5 years. DDAF incidence was lower in the DX ICD group for all burden cutoffs (p < 0.0001). However, after PS matching, DDAF rates were similar between groups, with no significant differences (p ≥ 0.36). Multivariate analysis identified age and 1-month right ventricular pacing percentage as predictors of DDAF across all burden cutoffs, with no effect based on device type or programmed basic rate. CONCLUSION: In patients without atrial pacing indication or history of clinical atrial fibrillation at implantation, the DX ICD demonstrated DDAF detection capabilities comparable to DDD ICDs in a real-world setting.
No takes yet. Share an insight, caveat, or question.
Mitacchione et al. (2025) conducted a cohort in Implantable cardioverter-defibrillator recipients without atrial pacing indication (n=1,329). DX ICD (single ventricular lead with floating atrial dipole) vs. Standard dual-chamber (DDD) ICD was evaluated on Incidence of newly detected device-detected subclinical atrial fibrillation (DDAF) at burden cutoffs of ≥ 15 min, ≥ 6 h, and ≥ 24 h (p=≥ 0.36). The DX ICD demonstrated comparable device-detected atrial fibrillation detection rates to standard dual-chamber ICDs after propensity score matching.
Synapse has enriched 10 related papers. Consider them for comparative context: